
Vice President, Development Sciences (Clinical Pharmacology & Nonclinical)
Lycia Therapeutics • San Francisco, California, US
Lycia Therapeutics is a biotechnology company using its proprietary lysosomal targeting chimera (LYTAC) platform to discover and develop best-in-class therapeutics that degrade extracellular and membrane-bound proteins.







